Trombembolia acută a ramurilor mici ale arterei pulmonare la un pacient cu cancer de prostată

Abstract

Pulmonary embolism is an important clinical entity with considerable mortality despite advances in diagnosis and treatment. The European guidelines for the diagnosis and management of PE report annual incidence rates of venous thrombosis and PE of approximately 0.5 to 1.0 per 1000 inhabitants. However, the actual figures are likely to be substantially higher because silent PE can develop in up to 40% to 50% of patients with deep vein thrombosis (DVT). If untreated, acute PE is associated with a significant mortality rate (as high as 30%), whereas the death rate of diagnosed and treated PE is 8%. It was estimated that 59% are deaths resulting from PE that remained undiagnosed during life and only 7% of the patients who died early are correctly diagnosed with PE before death. About 20% of patients with PE belong to the group with massive PE, 47% with submassive and the remaining 33% consist of small PE.